Isoelectric focusing (IEF) stands as a pivotal technique in biopharmaceutics, offering a precise method for separating and analyzing proteins based on their isoelectric points. In this process, proteins migrate through a pH gradient until they reach their isoelectric point, where they carry no net charge. This allows for unparalleled resolution in separating proteins with subtle differences in charge.
In the realm of biopharmaceutics, IEF finds applications in characterizing complex protein mixtures crucial for the development of biopharmaceuticals. It plays a vital role in quality control processes, aiding researchers in ensuring the purity and consistency of therapeutic proteins. The ability of IEF to separate closely related protein variants makes it indispensable in the biopharmaceutical industry, providing insights into the heterogeneity of protein samples.
As biopharmaceutics continues to advance, IEF remains a cornerstone technique, contributing to the understanding and optimization of protein-based drugs. Its high resolution and sensitivity make it an invaluable tool for researchers and scientists striving to unlock the full potential of biopharmaceuticals in the quest for improved therapeutic outcomes.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico